New Drug Helps Patients Stick To Weight-Loss Diet

Colleen Pierre The Baltimore Sun

Everybody is asking about the new appetite suppressant, Redux. Does it really work? Is it safe? Have we truly found the cure for obesity?

For people with significant obesity (approximately 30 percent above ideal weight), or people who are 20 percent above ideal weight with another health problem, such as heart disease, diabetes or high blood pressure, Redux can play an important role in triggering weight loss, which reduces health risks. But for people with just 10 pounds to 20 pounds to lose, it poses more health risks than it prevents.

Redux signals a breakthrough in the way we think about and treat obesity. We’ve finally gotten past the assumption that being overweight is just a sign of willful overindulgence. Science now acknowledges that natural body chemicals can misbehave and produce unwanted results.

Redux works by increasing the brain chemical serotonin, which leads to feelings of satisfaction, physical and emotional well-being and even of having had enough to eat. Redux doesn’t miraculously eliminate fat cells. Instead, it helps patients feel satisfied with less food, so it’s easier to stick to a weight-loss diet, according to Dr. Phillip DeVane of Wyeth-Ayerst Laboratories, which produces Redux.

Wyeth-Ayerst insists that Redux be used along with a healthful weight-loss diet, behavior modification techniques and a regular exercise program. The company even offers a patient starter kit suggesting sessions with a registered dietitian. The reason? Long-term studies show Redux is safe and effective up to one year. But the studies stop at that point, so we don’t know what happens down the road.

What we do know is that Redux works only while you take it. When you stop, you need strong lifestyle habits to manage the loss of those “had enough to eat” feelings. Why would anyone stop taking it? Because it is not approved for lifelong use, so your doctor is supposed to stop prescribing it after a while.

Some of the side effects, such as diarrhea, sleepiness, dry mouth or vivid dreams, are considered trivial and may subside. But one, primary pulmonary hypertension, although quite rare, can be fatal. According to Wyeth-Ayerst, European studies show people who used Redux for more than three months showed an increase in the rates of primary pulmonary hypertension from one or two in 1 million per year to about 18 per 1 million per year.

While that may sound frightening, it’s safer than remaining obese. Obesity increases risks for heart disease, high blood pressure, diabetes and some cancers and plays a part in 300,000 deaths each year.

Furthermore, we know that small weight losses of 10 percent to 20 percent of body weight (30 pounds to 60 pounds in a 300-pound person) can lower blood pressure, improve cholesterol and even improve diabetes management. It may also make exercise easier.

The hope for Redux is that it will help people with significant obesity make a successful start on lifestyle changes that can be maintained when the drug is no longer prescribed. That will take a determined effort, but it’s worth a try.

Thank you for visiting Spokesman.com. To continue reading this story and enjoying our local journalism please subscribe or log in.

You have reached your article limit for this month.

Subscribe now and enjoy unlimited digital access to Spokesman.com

Unlimited Digital Access

Stay connected to Spokane for as little as 99¢!

Subscribe for access

Already a Spokesman-Review subscriber? Activate or Log in

You have reached your article limit for this month.

Subscribe now and enjoy unlimited digital access to Spokesman.com

Unlimited Digital Access

Stay connected to Spokane for as little as 99¢!

Subscribe for access

Already a Spokesman-Review subscriber? Activate or Log in

Oops, it appears there has been a technical problem. To access this content as intended, please try reloading the page or returning at a later time. Already a Spokesman-Review subscriber? Activate or Log in